Indole-3-carbinol inhibits LPS-induced inflammatory response by blocking TRIF-dependent signaling pathway in macrophages

Food and Chemical Toxicology

Volumn 57, Issue , 2013, Pages 256-261

  Jiang, Jun ^a   Kang, Tae Bong ^a   Shim, Do Wan ^a   Oh, Na Hyun ^a   Kim, Tack Joong ^b   Lee, Kwang Ho ^a  

^a Konkuk University   (South Korea)

^b Yonsei University Wonju   (South Korea)

Author keywords

ALI; BALF; Indole 3 carbinol; Inflammation; TRIF

Indexed keywords

3 INDOLEMETHANOL; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; FEMALE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INDOLES; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PNEUMONIA; SIGNAL TRANSDUCTION;

EID: 84877103531     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.03.040     Document Type: Article

References (38)

1. Aggarwal B.B., Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 2005, 4:1201-1215.
2. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
3. Anzueto A. Exogenous surfactant in acute respiratory distress syndrome: more is better. Eur. Respir. J. 2002, 19:787-789.
4. Bellik Y., Hammoudi S.M., Abdellah F., Iguer-Ouada M., Boukraâ L. Phytochemicals to prevent inflammation and allergy. Recent Pat. Inflamm. Allergy Drug Discov. 2012, 6:147-158.
5. Bosma K., Fanelli V., Ranieri V.M. Acute respiratory distress syndrome: update on the latest developments in basic and clinical research. Curr. Opin. Anaesthesiol. 2005, 18:137-145.
6. Choi Y., Kim Y., Park S., Lee K.W., Park T. Indole-3-carbinol prevents diet-induced obesity through modulation of multiple genes related to adipogenesis, thermogenesis or inflammation in the visceral adipose tissue of mice. J. Nutr. Biochem. 2012, 23:1732-1739.
7. Coker R.K., Laurent G.J. Pulmonary fibrosis: cytokines in the balance. Eur. Respir. J. 1998, 11:1218-1221.
8. Conti G., Tambalo S., Villetti G., Catinella S., Carnini C., Bassani F., Sonato N., Sbarbati A., Marzola P. Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology. MAGMA 2010, 23:93-101.
9. Itoh K., Udagawa N., Kobayashi K., Suda K., Li X., Takami M., Okahashi N., Nishihara T., Takahashi N. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J. Immunol. 2003, 170:3688-3695.
10. Jacobs A.T., Ignarro L.J. Lipopolysaccharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in Raw264.7 macrophages. J. Biol. Chem. 2001, 276:47950-47957.
11. Jansson A.H., Eriksson C., Wang X. Lung inflammatory responses and hyperinflation induced by an intratracheal exposure to lipopolysaccharide in rats. Lung 2004, 182:163-171.
12. Jones B.W., Means T.K., Heldwein K.A., Keen M.A., Hill P.J., Belisle J.T., Fenton M.J. Different Toll-like receptor agonists induce distinct macrophage responses. J. Leukoc. Biol. 2001, 69:1036-1044.
13. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., Hoshino K., Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 2001, 167:5887-5894.
14. Kim J.J., Jiang J., Shim D.W., Kwon S.C., Kim T.J., Ye S.K., Kim M.K., Shin Y.K., Koppula S., Kang T.B., Choi D.K., Lee K.H. Anti-inflammatory and anti-allergic effects of Agrimonia pilosa Ledeb extract on murine cell lines and OVA-induced airway inflammation. J. Ethnopharmacol. 2012, 140:213-221.
15. Kim, Y.S., Young, M.R., Bobe, G., Colburn, N.H., Milner, J.A., 2009. Bioactive food components, inflammatory targets, and cancer, prevention. 2, 200-208.
16. Knapp S. LPS and bacterial lung inflammation models. In. Drug Discovery Today: Disease Models 2009, 6:113-118.
17. Lamontagne F., Briel M., Guyatt G.H., Cook D.J., Bhatnagar N., Meade M. Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials. J. Crit. Care 2010, 25:420-435.
18. Lee W.L., Downey G.P. Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care 2001, 7:1-7.
19. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
20. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
21. Manzi S., Wasko M.C. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann. Rheum. Dis. 2000, 59:321-325.
22. Matsuzaki Y., Koyama M., Hitomi T., Kawanaka M., Sakai T. Indole-3-carbinol activates the cyclin-dependent kinase inhibitor p15(INK4b) gene. FEBS Lett. 2004, 576:137-140.
23. McKay A., Leung B.P., McInnes I.B., Thomson N.C., Liew F.Y. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J. Immunol. 2004, 172:2903-2908.
24. Meduri G.U., Annane D., Chrousos G.P., Marik P.E., Sinclair S.E. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 2009, 136:1631-1643.
25. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
26. Nonas S., Miller I., Kawkitinarong K., Chatchavalvanich S., Gorshkova I., Bochkov V.N., Leitinger N., Natarajan V., Garcia J.G., Birukov K.G. Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury. Am. J. Respir. Crit. Care. Med. 2006, 173:1130-1138.
27. Pechulis R., Satti A.G., Wang P., Qin X.B., Criner G.J. Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Critical Care Study Guide 2010, Springer-Verlag, Berlin, pp. 282-304.
28. Philippakis G.E., Lazaris A.C., Papathomas T.G., Zissis C., Agrogiannis G., Thomopoulou G., Nonni A., Xiromeritis K., Nikolopoulou-Stamati P., Bramis J., Patsouris E., Perrea D., Bellenis I. Adrenaline attenuates the acute lung injury after intratracheal lipopolysaccharide instillation: an experimental study. Inhal. Toxicol. 2008, 20:445-453.
29. Rhee S.H., Hwang D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J. Biol. Chem. 2000, 275:34035-34040.
30. Rogan E.G. The natural chemopreventive compound indole-3-carbinol: state of the science. In Vivo. 2006, 20:221-228.
31. Samavati L., Rastogi R., Du W., Huttemann M., Fite A., Franchi L. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol. Immunol. 2009, 46:1867-1877.
32. Schluger N.W., Rom W.N. The host immune response to tuberculosis. Am. J. Respir. Crit. Care. Med. 1998, 157:679-691.
33. Steinmetz K.A., Potter J.D. Vegetables, fruit, and cancer prevention: a review. J. Am. Diet. Assoc. 1996, 96:1027-1039.
34. Shu Y.Z. Recent natural products based drug development: a pharmaceutical industry perspective. J. Nat. Prod. 1997, 61:1053-1071.
35. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 2001, 107:7-11.
36. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., Williams B.R., Major J., Hamilton T.A., Fenton M.J., Vogel S.N. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 2002, 3:392-398.
37. Verhoeven D.T., Verhagen H., Goldbohm R.A., van den Brandt P.A., van Poppel G. A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem. Biol. Interact. 1997, 103:79-129.
38. Wang J.X., Hou L.F., Yang Y., Tang W., Li Y., Zuo J.P. SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-kappaB pathways in Raw264.7 macrophages. Acta. Pharmacol. Sin. 2009, 30:1428-1435.